Table 1 Baseline clinical characteristics of the study population.
Characteristics | All patients (n = 55) |
|---|---|
Age of diagnose, years | 60.4 (45–75) |
Male sex | 48 (87.27%) |
ECOG performance status | |
0 | 31 (56.36%) |
1 | 24 (43.64%) |
Stooler’s dysphagia score | |
0 | 12 (21.83%) |
1 | 19 (34.55%) |
2 | 21 (38.17%) |
3 | 3 (5.45%) |
Histology | |
Squamous cell carcinoma | 55 (100%) |
Overall clinical staging | |
I | 1 (1.82%) |
II | 7 (12.73%) |
III | 27 (49.09%) |
IV | 20 (36.36%) |
Preoperative T status | |
cT1 | 3 (5.45%) |
cT2 | 9 (16.36%) |
cT3 | 24 (43.64%) |
cT4 | 19 (34.55%) |
Preoperative N status | |
cN0 | 8 (14.55%) |
cN1 | 25 (45.45%) |
cN2 | 17 (30.91%) |
cN3 | 5 (9.09%) |
Preoperative M status | |
cM0 | 55 (100%) |
Tumor grade (Differentiation) | |
Well | 5 (9.09%) |
Well-moderate | 2 (3.64%) |
Moderate | 31 (56.36%) |
Moderate-poor | 4 (7.27%) |
Poor | 13 (23.64%) |
Tumor location | |
Middle | 16 (29.09%) |
Middle-lower | 21 (38.17%) |
Lower | 18 (32.73%) |
